Vitamin D reduces VSMC foam cell formation and protects against AS progression

J Endocrinol. 2025 Mar 7;265(1):e240056. doi: 10.1530/JOE-24-0056. Print 2025 Apr 1.

Abstract

The role that vascular smooth muscle cell (VSMC)-derived foam cells play as drivers of atherosclerosis has been an increasing focus of recent research interest. Toll-like receptor 4 (TLR4) has been identified as a regulator of the formation of VSMC foam cells, while vitamin D can reportedly suppress macrophage-derived foam cell development. Our aim is to investigate whether vitamin D can similarly suppress the formation of VSMC foam cells, as well as the role of TLR4 in this pathogenic context. The impact of vitamin D on VSMC-derived foam cell and atherosclerotic plaque formation was assessed, and the expression of cholesterol transport-related genes and TLR4 was assessed in ApoE-/- mice. The impact of 1,25(OH)2D3 on the ox-LDL-mediated formation of foam cells and the underlying molecular mechanisms were also examined in VSMCs cultured in vitro. Supplemental vitamin D administration resulted in a pronounced reduction in aortic atherosclerotic plaque formation and the development of SMA-α-positive foam cells. Vitamin D further suppressed TLR4, CD36 and SR-A in atherosclerotic plaque lesions while promoting ABCA1, ABCG1 and LXR-α upregulation. 1,25(OH)2D3 significantly reduced Dil-ox-LDL uptake and increased NBD-LDL efflux in VSMCs, in addition to suppressing TLR4, CD36 and SR-A expression, while upregulating ABCA1, ABCG1 and LXR-α. TLR4 knockdown impaired VSMC foam cell formation, while 1,25(OH)2D3-induced JNK activation suppressed TLR4 signaling and promoted VSMC foam cell development. Our study reveals that vitamin D can reduce VSMC foam cell formation and protect against atherosclerotic progression through the JNK-TLR4 signaling pathway.

Keywords: athrosclerosis; foam cell; toll-like receptor 4; vascular smooth muscle cells; vitamin D.

MeSH terms

  • ATP Binding Cassette Transporter 1 / genetics
  • ATP Binding Cassette Transporter 1 / metabolism
  • ATP Binding Cassette Transporter, Subfamily G, Member 1 / genetics
  • ATP Binding Cassette Transporter, Subfamily G, Member 1 / metabolism
  • Animals
  • Apolipoproteins E / genetics
  • Atherosclerosis* / genetics
  • Atherosclerosis* / metabolism
  • Atherosclerosis* / pathology
  • Atherosclerosis* / prevention & control
  • CD36 Antigens / genetics
  • CD36 Antigens / metabolism
  • Calcitriol / pharmacology
  • Cells, Cultured
  • Disease Progression
  • Foam Cells* / drug effects
  • Foam Cells* / metabolism
  • Lipoproteins, LDL / metabolism
  • Liver X Receptors / genetics
  • Liver X Receptors / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Knockout, ApoE
  • Muscle, Smooth, Vascular* / cytology
  • Muscle, Smooth, Vascular* / drug effects
  • Muscle, Smooth, Vascular* / metabolism
  • Muscle, Smooth, Vascular* / pathology
  • Myocytes, Smooth Muscle* / drug effects
  • Myocytes, Smooth Muscle* / metabolism
  • Plaque, Atherosclerotic / metabolism
  • Plaque, Atherosclerotic / pathology
  • Signal Transduction / drug effects
  • Toll-Like Receptor 4 / genetics
  • Toll-Like Receptor 4 / metabolism
  • Vitamin D* / pharmacology

Substances

  • Toll-Like Receptor 4
  • Vitamin D
  • Tlr4 protein, mouse
  • ATP Binding Cassette Transporter, Subfamily G, Member 1
  • ATP Binding Cassette Transporter 1
  • oxidized low density lipoprotein
  • CD36 Antigens
  • Lipoproteins, LDL
  • Calcitriol
  • Liver X Receptors
  • Apolipoproteins E
  • ABCG1 protein, mouse